Herpangina
MONDO:0005791A viral infectious disease that results in infection located in mouth, has material basis in Human coxsackievirus A16, has material basis in Human enterovirus 71, has material basis in group B coxsackievirus, or has material basis in echoviruses, which are transmitted by ingestion of food contaminated with feces, transmitted by contact with pharyngeal secretions, or transmitted by droplet spread of oronasal secretions. The infection has symptom fever, has symptom sore throat, and has symptom lesions in the back area of the mouth, particularly the soft palate or tonsillar pillars.
6 clinical trials for this condition and its sub-types, 3 tagged with Herpangina itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New vaccine aims to tackle two viruses behind hand, foot, and mouth disease
Vaccine CompletedThis clinical trial tested a new vaccine designed to protect against two viruses (EV71 and CA16) that cause hand, foot, and mouth disease and herpangina. The study involved 744 healthy adults and children, including kids as young as 6 months. Researchers checked the vaccine's saf…
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 28, 2026 00:00 UTC
-
New vaccine aims to shield kids from hand, foot, and mouth disease
Vaccine CompletedThis study tested a new vaccine designed to protect against hand, foot, and mouth disease and herpangina, which are common viral infections in children. The trial involved 552 healthy adults and children aged 6 months to 12 years. Participants received either a low, medium, or hi…
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 09:10 UTC